Research [41] has shown that reduced levels of HDL cholesterol or apolipoprotein A1 correlate with elevated risks of multiple myeloma, MPN, non-Hodgkin lymphoma, and breast, lung, and nervous system cancers. The gene discussed is APOA1; the disease is non-Hodgkin lymphoma.